Fig. 3From: The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, ChinaThe ROC curve of age, T lymphocyte and CRP of the progressive and stable patients. a ROC curve of age; b ROC curve of T lymphocyte; c ROC curve of C-reactive proteinBack to article page